Diamonds and Dogs
The Dow hit 19,999 while railroader, Greenbrier (GBX) steamed forward following earnings. The earnings were actually disappointing coming in at 79 cents a share verse estimates of 83 cents. Revenue fell 31.2% year over year to $552.3 million well ahead of consensus. The company reaffirmed guidance for the full year of $3.25-3.37 vs. $3.37. Good enough to get the stock up 16% to a new 52 week high.
Big week for biotechs, but not Teva Pharma (TEVA). The stock dropped 3% on heavy volume after lowering guidance for the year. The generic drug maker cut earnings per share guidance for 2017 to a range of $4.90 to $5.30, which is below the current analyst consensus of $5.41. Teva also cut revenue guidance to $23.8 billion to $24.5 billion, while analysts had been looking for revenue of $24.8 billion. The company noted that it expects mid-single-digit price erosion to continue.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.